Diberdayakan oleh Blogger.

Popular Posts Today

Stocks barely higher ahead of Fed decision

Written By Unknown on Rabu, 19 Maret 2014 | 23.14

NEW YORK — Stocks were mixed in morning trading Wednesday as investors awaited the results of the Federal Reserve's first policy meeting under its new chair, Janet Yellen. Technology stocks struggled after Oracle reported earnings and revenue that fell short of what investors were expecting.

KEEPING SCORE: The Dow Jones industrial average rose 14 points, or 0.1 percent, to 16,350 as of 11:15 a.m. Eastern. The Standard & Poor's 500 index was essentially unchanged at 1,872 and the Nasdaq composite was down eight points, or 0.2 percent, to 4,325.

ORACLE LAGS: Technology giant Oracle fell $1.02, or 3 percent, to $37.82. The database software maker reported a slight rise in revenue and profits from a year ago, but the results came in short of analysts' predictions. Oracle's results also dragged down IBM, SAP and Microsoft. Oracle and Microsoft carry a lot of weight in the Nasdaq composite and helped pull the index lower.

YELLEN'S DEBUT: Investors will be watching closely for any hints of how Yellen will differ from her predecessor, Ben Bernanke. The central bank is expected to announce a further reduction of its economic stimulus program, reducing its monthly bond purchases from $65 billion a month to $55 billion. Yellen also will preside over her first news conference as Fed chair this afternoon.

HOMEBUILDERS: KB Homes, one of the nation's largest homebuilders, jumped $1.40, or 8 percent, to $19.08 after the company reported much higher profits than investors were expecting. KB earned 12 cents a share, four cents more than analysts had forecast. The company also said the average selling price of a new home rose 12 percent from last year. Other homebuilders also rose. D.R. Horton, PulteGroup and Toll Brothers gained 2 percent or more.

WEATHER HITS FEDEX: Shipping company FedEx was up 63 cents, or 0.5 percent, to $139.19. FedEx earnings missed analysts' estimates, but the company said it mostly had to do with the winter storms in January and February, which cut into the company's shipping volumes for several weeks.

BONDS AND COMMODITIES: Bond prices fell slightly. The yield on the 10-year Treasury note rose to 2.69 percent from 2.67 percent late Tuesday. The price of oil edged down 17 cents to $98.72 a barrel. Gold fell $19.70 to $1,339.50 an ounce.


23.14 | 0 komentar | Read More

JPMorgan selling physical commodities business

NEW YORK — JPMorgan said on Wednesday that it has made a deal to sell its physical commodities business for $3.5 billion, after new regulations crimped its ability to control power plants, warehouses, and oil refineries.

If it's approved by regulators, the deal would put the commodities business in the hands of energy and commodities trading company Mercuria Energy Group Ltd.

Big banks have long profited from price swings in metals, energy, and other commodities. But some had branched out into owning physical facilities. Last summer JPMorgan said that the possibility of new regulations on whether banks could continue to do that was a factor behind its decision to consider selling some of its physical commodities business, which includes metals and energy assets.

JPMorgan Chase & Co. said Wednesday that after the sale it will still provide traditional banking activities in the commodities markets. It will also continue to make markets, provide liquidity and risk management and offer advice to global companies and institutions.

The deal, which is not expected to have a material impact on JPMorgan's earnings, is targeted to close in the third quarter.

JPMorgan shares rose 13 cents to $58.19 in morning trading. Its shares have risen more than 18 percent over the past year.


23.14 | 0 komentar | Read More

Markets await Fed decision and Yellen remarks

LONDON — Markets were largely in wait and see mode Wednesday ahead of the latest policy decision from the U.S. Federal Reserve and subsequent remarks from its new chief.

In spite of some recent soft economic data in the wake of bad weather across large parts of the U.S., most analysts expect the Fed to continue to reduce its monetary stimulus at the speed it has already set, trimming its monthly bond purchases by another $10 billion to $55 billion. The meeting is the first under the leadership of new Chair Janet Yellen.

"There is little reason to expect otherwise," said Neil MacKinnon, global macro strategist at VTB Capital. "The Fed is naturally going to move gradually in normalizing its monetary policy, if for no other reason that it has to be careful that it does not upset the U.S. economic recovery."

In Europe, the FTSE 100 index of leading British shares was down 0.2 percent at 6,593 while Germany's DAX rose 0.6 percent to 9,295. The CAC-40 in France was 0.2 percent higher at 4,323.

In the U.S., the Dow Jones industrial average was up 0.2 percent at 16,360 while the broader S&P 500 index rose 0.1 percent to 1,874.

The modest gains come on top of the advance earlier this week when investors were relieved by the limited sanctions on Russia announced by the U.S. and the European Union following the referendum in the Ukrainian region of Crimea. However, concerns over the situation in Crimea, which is now effectively part of Russia, remain after masked Russian-speaking troops seized control of Ukrainian naval headquarters.

Earlier in Asia, stocks traded in narrow ranges with Tokyo's Nikkei 225 closing up 0.4 percent at 14,462.52. China's Shanghai Composite Index dropped 0.2 percent to 2,021.73 while Hong Kong's Hang Seng shed 0.1 percent to 21,568.69.

Elsewhere, the focus was on the Fed, too, with trading fairly muted. Among currencies, the euro was down 0.2 percent at $1.3905 while the dollar rose 0.1 percent to 101.56 yen. Meanwhile, a barrel of benchmark New York crude was up 2 cents at $98.90.


23.14 | 0 komentar | Read More

US files charge against Toyota, $1.2B penalty

WASHINGTON — The government announced a $1.2 billion settlement with Toyota Motor Corp. on Wednesday and filed a criminal charge alleging the company defrauded consumers by issuing misleading statements about safety issues in Toyota and Lexus vehicles.

Attorney General Eric Holder said it is the largest financial penalty of its kind ever imposed on an auto company. Under a deferred prosecution agreement, an independent monitor will review policies, practices and procedures at the company.

The action concludes a four-year criminal investigation into the Japanese automaker's disclosure of safety problems, which focused on whether Toyota was forthright in reporting problems related to unintended acceleration troubles.

"Rather than promptly disclosing and correcting safety issues ... Toyota made misleading public statements to consumers and gave inaccurate facts to members of Congress," Holder told a news conference.

Toyota said that at the time of the recalls, "we took full responsibility for any concerns our actions may have caused customers, and we rededicated ourselves to earning their trust," said Christopher P. Reynolds, chief legal officer of Toyota Motor North America. "In the more than four years since these recalls, we have gone back to basics at Toyota to put our customers first."

Toyota said it had "made fundamental changes to become a more responsive and customer-focused organization, and we are committed to continued improvements."

Starting in 2009, Toyota issued massive recalls, mostly in the U.S., totaling more than 10 million vehicles for various problems including faulty brakes, gas pedals and floor mats. From 2010 through 2012, Toyota Motor Corp. paid fines totaling more than $66 million for delays in reporting unintended acceleration problems.

The National Highway Traffic Safety Administration never found defects in electronics or software in Toyota cars, which had been targeted as a possible cause.

Starting in 2009, Toyota issued massive recalls, mostly in the U.S., totaling more than 10 million vehicles for various problems including faulty brakes, gas pedals and floor mats. From 2010 through 2012, Toyota Motor Corp. paid fines totaling more than $66 million for delays in reporting unintended acceleration problems.

The settlement continues a string of bad publicity for Toyota, which before the unintended acceleration cases had a bulletproof image of reliability. Since the cases surfaced, the company's brand image has been damaged and it has lost U.S. market share as competition has intensified.

Last year, Toyota agreed to pay more than $1 billion to resolve hundreds of lawsuits claiming that owners of its cars suffered economic losses because of the recalls. But that settlement did not include wrongful death and injury lawsuits that have been consolidated in California state and federal courts.

In December, Toyota filed court papers after a four-year legal battle saying that it's in settlement talks on nearly 400 U.S. lawsuits, but other cases aren't included in the talks.

The negotiations come less than two months after an Oklahoma jury awarded $3 million in damages to the injured driver of a 2005 Camry and to the family of a passenger who was killed.

The ruling was significant because Toyota had won all previous unintended acceleration cases that went to trial. It was also the first case where attorneys for plaintiffs argued that the car's electronics — in this case the software connected to a midsize Camry's electronic throttle-control system — were the cause of the unintended acceleration.

At the time, legal experts said the Oklahoma verdict might cause Toyota to consider a broad settlement of the remaining cases. Until then, Toyota had been riding momentum from several trials where juries found it was not liable.

Toyota has blamed drivers, stuck accelerators or floor mats that trapped the gas pedal for the acceleration claims that led to the big recalls of Camrys and other vehicles. The company has repeatedly denied its vehicles are flawed.

No recalls have been issued related to problems with onboard electronics. In the Oklahoma case, Toyota attorneys theorized that the driver mistakenly pumped the gas pedal instead of the brake when her Camry ran through an intersection and slammed into an embankment.

But after the verdict, jurors told AP they believed the testimony of an expert who said he found flaws in the car's electronics.

Toyota also had to pay millions for recalls, as well as a series of fines totaling $68 million to the NHTSA, the U.S. government's road safety watchdog, for being slow to report acceleration problems.

Still, the payments won't hurt Toyota's finances very much. In its last fiscal quarter alone, Toyota posted a $5.2 billion profit, crediting a weak yen and strong global sales.

Toyota's U.S. market share, however, has fallen more than 4 percentage points since unintended acceleration came to the forefront in August of 2009, when a California Highway Patrol officer and three others were killed in a fiery crash. The officer's runaway car was traveling more than 120 mph when it crashed and burst into flames. One of his family members called police about a minute before the crash to report the vehicle had no brakes and the accelerator was stuck.

At the time, Toyota controlled 17.8 percent of the U.S. market. Gas prices were high, playing to Toyota's fuel-efficient small cars and hybrids. Detroit automakers were in serious financial trouble and had few fuel-efficient cars for sale.

By last month, though, Toyota's share fell to 13.3 percent, according to Autodata Corp., as the company faced intense competition in small and midsize cars from resurgent Detroit automakers and Korean brands Hyundai and Kia.

The Toyota criminal charge and settlement could foreshadow what's in store for General Motors. The same U.S. attorney's office is investigating the Detroit auto giant for its slow response to a faulty ignition switch problem in older compact cars that has been linked to at least 31 crashes and 12 deaths. NHTSA also is investigating whether GM withheld information about the problem and could fine the automaker $35 million.

__

Krisher contributed from Detroit


23.14 | 0 komentar | Read More

Health law concerns for cancer centers

WASHINGTON — Cancer patients relieved that they can get insurance coverage because of the new health care law may be disappointed to learn that some the nation's best cancer hospitals are off-limits.

An Associated Press survey found examples coast to coast. Seattle Cancer Care Alliance is excluded by five out of eight insurers in Washington state's insurance exchange. MD Anderson Cancer Center says it's in less than half of the plans in the Houston area. Memorial Sloan-Kettering is included by two of nine insurers in New York City and has out-of-network agreements with two more.

Doctors and administrators say they're concerned. So are some state insurance regulators.

In all, only four of 19 nationally recognized comprehensive cancer centers that responded to AP's survey said patients have access through all the insurance companies in their state exchange.

Not too long ago, insurance companies would have been vying to offer access to renowned cancer centers, said Dan Mendelson, CEO of the market research firm Avalere Health. Now the focus is on costs.

"This is a marked deterioration of access to the premier cancer centers for people who are signing up for these plans," Mendelson said.

Those patients may not be able get the most advanced treatment, including clinical trials of new medications.

And there's another problem: It's not easy for consumers shopping online in the new insurance markets to tell whether top-level institutions are included in a plan. That takes additional digging by the people applying.

"The challenges of this are going to become evident ... as cancer cases start to arrive," Norman Hubbard, executive vice president of Seattle Cancer Care Alliance, said.

Advocates for cancer patients are in a quandary.

Before President Barack Obama's health care law, a cancer diagnosis could make you uninsurable. Now, insurers can't turn away people with health problems or charge them more. Lifetime dollar limits on policies, once a financial trapdoor for cancer patients, are also banned.

"Patients may have fewer choices of doctors and hospitals in some exchange plans than others ... but the rules for such plans go a long way toward remedying the most severe problems that existed for decades," said Steve Weiss, spokesman for the American Cancer Society Cancer Action Network.

The new obstacles are more subtle.

To keep premiums low, insurers have designed narrow networks of hospitals and doctors. The government-subsidized private plans on the exchanges typically offer less choice than Medicare or employer plans.

By not including a top cancer center an insurer can cut costs. It may also shield itself from risk, delivering an implicit message to cancer survivors or people with a strong family history of the disease that they should look elsewhere.

For now, the issue seems to be limited to the new insurance exchanges. But it could become a concern for Americans with job-based coverage too if employers turn to narrow networks.

The AP surveyed 23 institutions around the country that are part of the National Comprehensive Cancer Network. Two additional institutions that joined this week were not included in the survey.

Cancer network members are leading hospitals that combine the latest clinical research and knowledge with a multidisciplinary approach to patient care. They say that patients in their care have better-than-average survival rates. The unique role of cancer centers is recognized under Medicare. Several are exempt from its hospital payment system, instituted to control costs.

The AP asked the centers how many insurance companies in their state's exchange included them as a network provider.

Of the 19 that responded, four reported access through all insurers: the Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore; Fox Chase Cancer Center in Philadelphia; Duke Cancer Institute in Durham, N.C.; and Vanderbilt-Ingram Cancer Center in Nashville, Tenn. One caveat: Some insurers did not include these cancer centers on certain low-cost plans.

Two centers have special circumstances. The best known is St. Jude's Children's Research Hospital in Memphis, Tenn. Treatment there is free as long as children have a referral.

For the remaining 13, the gaps are evident.

In Buffalo, N.Y., Roswell Park Cancer Institute is included by five of seven insurers in its region. But statewide, the picture is much different: Roswell Park is not included by 11 of 16 insurers. Dr. Willie Underwood, associate professor of surgical oncology at the teaching hospital, says that's a problem.

"Overall, when you look at the Affordable Care Act, it improves access to cancer care," Underwood said. "When it comes down to the exchanges, there are some concerns that we have. That is not being critical, that is being intelligent. There are some things we should talk about ... before they start becoming a problem."

Melanie Lapidus, vice president for managed care at Barnes-Jewish Hospital in St. Louis, home to Siteman Cancer Center, said she doesn't think patients realize the exchanges offer a more restrictive kind of private insurance.

Lapidus cited Anthem Blue Cross and Blue Shield, which includes Siteman in many of its plans outside the Missouri exchange, but none within the exchange.

"We have had many people say to us, 'I picked Anthem because you guys are always in their products, and I assumed you would be in their exchange products,'" Lapidus said. "It's still hard to tell who is in network and who is not."

In a statement, Anthem said its network was based on research involving thousands of consumers and businesses. "What we learned was that people are willing to make trade-offs in order to have access to affordable health care," the company said. "Our provider networks reflect this."

Huntsman Cancer Institute in Salt Lake City is included by five of six Utah insurers, but Mark Zenger, who manages the center's negotiations with insurance companies, said he's concerned about getting left out by Humana, a major carrier.

"We are worried about the potential to have these Humana exchange members seek treatment and have no other option," Zenger said.

Humana spokesman Tom Noland said patients can have access to Huntsman for complex procedures, on a case-by-case basis.

Some state insurance regulators see a problem.

"I want insurers to be able to innovate and come up with new product designs," said Mike Kreidler, insurance commissioner for Washington state. "At the same time, there is a requirement for regulators like myself to be vigilant to make sure there aren't unreasonable compromises."

The Obama administration says it has notified insurers that their networks will get closer scrutiny for next year in the 36 states served by the federal exchange. Cancer care will be a priority, it says.

___

Associated Press writers Sheila Burke in Nashville, Tenn., Kim Chandler in Montgomery, Ala., Emery Dalesio in Raleigh, N.C., Jeff Karoub in Detroit, Brady McCombs in Salt Lake City, Christine Scalora in Lincoln, Neb., and Christopher Weber in Los Angeles contributed to this report.


23.14 | 0 komentar | Read More

List: Access to cancer centers under health law

Some of the nation's top cancer care centers are concerned about access for patients who purchase policies through the new health insurance markets, also called exchanges.

The Associated Press asked 23 institutions that are part of the National Comprehensive Cancer Network whether they were included in the networks of insurance companies operating on their state's exchange. Here are the responses they provided:

—Fred & Pamela Buffett Cancer Center, Omaha, Neb.

In-network with three of four exchange insurers, but one of them includes Buffett only on some plans. A fourth insurer does not include Buffett.

—City of Hope, Los Angeles.

In-network for one of three major insurers; a fourth is a health maintenance organization with its own hospital system.

—Dana-Farber, Boston.

No response.

—Duke Cancer Institute, Durham, N.C.

In-network with the two insurers on the exchange, although not included in a low-price option.

—Fox Chase Cancer Center, Philadelphia.

In-network for the two dominant carriers in the market.

—Huntsman Cancer Institute, Salt Lake City.

In-network with five of six insurers.

—Hutchinson/Seattle Cancer Care Alliance, Seattle.

In-network with three of eight insurers on the state's exchange.

—Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore.

In-network for all six exchange insurers, although some individual plans may not offer access.

—Memorial Sloan-Kettering, New York.

In-network with two of nine exchange insurers in New York City, two of 16 statewide. Has out-of-network agreements with two more carriers.

—Moffit Cancer Center, Tampa, Fla.

In-network for three of six insurers offering plans in multiple Florida counties.

—Ohio State University/James/Solove, Columbus, Ohio.

No response.

—Roswell Park Cancer Institute, Buffalo, N.Y.

In-network with five of seven insurers in its local area, but only five of 16 statewide.

—Siteman Cancer Center/Barnes-Jewish, St. Louis.

In-network for some of the plans offered by one of two insurers on the state exchange.

—St. Jude Children's Research Hospital, Memphis, Tenn.

Treatment is free as long as children have a referral.

—Stanford Cancer Institute, Stanford, Calif.

No response.

—University of Alabama at Birmingham, Birmingham, Ala.

In-network with dominant carrier of two insurers on exchange.

—UC San Diego Moores Cancer Center, La Jolla, Calif.

In-network with one insurer, by design.

—UCSF Helen Diller Comprehensive Cancer Center, San Francisco.

In-network for two of nine insurers in the northern California market.

—University of Colorado Cancer Center, Aurora, Colo.

In-network for all plans with six of 10 carriers; included on some plans by three others.

—University of Michigan Comprehensive Cancer Center, Ann Arbor, Mich.

In-network for eight of 12 insurers, although not in every plan.

—MD Anderson Cancer Center, Houston.

In-network for two of 11 insurers in the state's exchange, and 43 percent of individual plans in Houston area.

—Vanderbilt-Ingram Cancer Center, Nashville, Tenn.

All four insurers have Vanderbilt, but one company does not include it in its least expensive plan.


23.14 | 0 komentar | Read More

Rough winter hurts General Mills 3Q sales

MINNEAPOLIS — Rough winter weather took a bite out of General Mills' fiscal third-quarter sales, and the cereal maker's results missed Wall Street expectations.

The maker of Cheerios, Yoplait and Betty Crocker products said Wednesday that its fiscal third-quarter net income rose 3 percent, free of a charge that hurt its results a year earlier.

For the three months that ended Feb. 23, the company earned $410.6 million, or 64 cents per share. That's up from $398.4 million, or 60 cents per share, a year earlier.

Last year's third quarter included a $6.1 million charge.

Removing certain items, earnings were 62 cents per share. Analysts expected 64 cents per share, according to a FactSet survey.

Revenue dipped 1 percent to $4.38 billion from $4.43 billion, hindered by bad winter weather, lower volumes and unfavorable foreign currency translation.

Wall Street was calling for $4.41 billion in revenue.

U.S. retail sales declined 2 percent as the company dealt with higher dairy costs and increased marketing and merchandising costs for its domestic yogurt business.

The yogurt business has been challenged by upstart competitors such as Chobani selling Greek yogurt.

Sales for the conveniences stores and food-service unit dropped 7 percent due to the winter weather and lower prices on some product lines.

Sales improved in Europe and the Asia Pacific region, which offset weakness in Latin America and Canada.

General Mills Inc. maintained its forecast for strong double-digit growth in adjusted earnings per share for the fourth quarter. The Minneapolis company also reaffirmed its fiscal 2014 guidance for adjusted earnings between $2.87 and $2.90 per share.

Analysts predict full-year earnings of $2.87 per share.

Shares of General Mills rose 30 cents to $51.01 in morning trading.


23.14 | 0 komentar | Read More

IBM's Watson to help sequence cancer DNA

NEW YORK — IBM and its Watson cloud computing system are partnering with the New York Genome Center to help it sequence DNA for the treatment of brain cancer.

New York Genome will use IBM's "Jeopardy!" champion system to sequence the DNA of cancer tumors at much faster rate than would be possible if done by a human being.

Dr. Robert Darnell, the Genome Center's president, CEO and scientific director, says that once doctors know a tumor's genetic makeup, they can determine the best course of treatment for a particular patient.

Armonk, N.Y.-based IBM Corp. already has a partnership with Memorial Sloan-Kettering Cancer Center, where Watson is also used to help treat cancer.


23.14 | 0 komentar | Read More

French court upholds prison for rogue trader

PARIS — France's highest court upheld Wednesday a prison sentence for one-time rogue trader Jerome Kerviel but threw out the 4.9 billion euros ($7 billion) in civil damages he'd been ordered to pay back.

Kerviel was convicted in 2010 of carrying out one of the biggest trading frauds in history that almost took down his bank, Societe Generale, with 4.9 billion euros in losses. He sees himself as a victim of a system that turned a blind eye to his illegal trades as long as they made money for the bank.

Kerviel had appealed the sentence of three years in prison, which had already been upheld once before by a lower appeals court.

In a statement, the high court said Wednesday that the lower court decision had not taken into account faults committed by Kerviel's former employer, French bank Societe Generale, when it ordered ordered Kerviel to repay the bank's entire losses in the fraud.

Kerviel is currently in Italy, walking back to Paris on a pilgrimage after meeting the pope. Television images showed him wearing a red jacket and red backpack, walking swiftly and trying to ignore the numerous journalists trailing him. He made no statement.

Outside the courtroom in Paris, Kerviel's lawyers claimed a partial victory.

"The errors of Societe Generale were at the heart of the concerns expressed by the judicial system, and it appears at the least surprising to lock up Jerome Kerviel when the existence of significant errors on behalf of his employer — and the consequences of these errors on events attributed to him — were affirmed," said Patrice Spinosi.

The high court ordered the civil damages to be retried by an appeals court in Versailles.

The bank's lawyer Jean Veil said that in the new trial the bank will explain that they knew "from the moment that these events were discovered, that there were errors in our system, which we've repaired and spent hundreds of millions to be able to change our control system."

The appeals court had upheld the October 2010 conviction of Kerviel for forgery, breach of trust and unauthorized computer use for covering up bets worth nearly 50 billion euros — more than the market value of the entire bank. It sentenced him to a five-year prison term — with two years suspended — and ordered he pay 4.9 billion euros in damages.

An internal report by the bank, however, found managers failed to follow up on 74 different alarms about Kerviel's activities.

Banned for life from working in the financial industry, Kerviel was making 2,300 euros a month ($3,150 at the time) as a computer consultant after leaving the bank. Societe Generale had paid him less than 100,000 euros a year ($155,700) with bonuses, a modest sum for the 1.4 billion euros in profits he earned for the bank in 2007.

A few of the bank's executives resigned in the scandal's aftermath, including longtime Chairman Daniel Bouton. Kerviel's superiors were questioned in the probe, but none of them faced charges.

___

Follow Greg Keller on Twitter at https://twitter.com/Greg_Keller


23.14 | 0 komentar | Read More

FedEx profit up, but misses expectations

DALLAS — FedEx Corp. says its latest quarterly profit rose 5 percent from a year ago despite storms that raised the company's costs, but the results were below analysts' expectations.

The company's ground-shipping segment is doing better, but the express-delivery business is flat and customers continue to shift to slower, cheaper services for international shipments.

The package-delivery giant said Wednesday that net income in the quarter that ended Feb. 28 rose to $378 million, or $1.23 per share, from $361 million, or $1.13 per share, a year ago. Analysts surveyed by FactSet expected $1.45 per share.

Revenue rose 3 percent to $11.30 billion from $11 billion, missing Wall Street's forecast of $11.43 billion.

The weak results drove FedEx to lower its forecast of full-year earnings. However, FedEx expects fiscal fourth-quarter earnings of between $2.25 and $2.50 per share, which leaves room to beat analysts' prediction of $2.34 per share.

FedEx said that weather reduced operating income by $125 million in the December-to-February third quarter. Snow, ice and freezing temperatures slowed the company's trucks and planes and raised costs for everything from de-icing to overtime. Shipments dropped off during storms because some retail shippers in the East and Midwest closed.

Rival United Parcel Service Co. struggled to keep up with peak volumes just before Christmas — traffic was heavier and later in the season than UPS expected.

FedEx Chairman and CEO Fred Smith said that his company handled December loads but will be careful in managing residential e-commerce shipments.

"The biggest challenge is the fact that so much of the business comes in such a short period of time, and obviously it is not possible to make these enormous capital investments for two or three weeks out of the year," Smith said on a conference call with analysts. "You can clearly go broke trying to deliver non-compensatory packages into people's homes."

Customers are limiting spending on higher-priced services. FedEx said that it was continuing to see a shift toward less profitable international services — the volume of international economy-class shipments rose 8 percent.

The Memphis, Tenn.-based company is still buying back its own stock, which reduced the number of shares by 3 percent from a year ago and boosted earnings per share.

Helane Becker, an analyst at Cowen and Co., said that investors would "give the company some slack" for the disappointing third quarter because of the slightly upbeat forecast for the May quarter and FedEx's moves to boost profit in its big express operations.

FedEx shares rose 56 cents to $139.13 in morning trading Wednesday. They began the day down 3.6 percent for this year after gaining 57 percent in 2013.


23.14 | 0 komentar | Read More
techieblogger.com Techie Blogger Techie Blogger